TABLE 1.
Results of body composition analysis of patients with COVID-19 determined from CT1
| Body composition measurement | Frequency, n (%) |
|---|---|
| Obesity | |
| High SFI (14): males >50.0 cm2/m2; females >42.0 cm2/m2 | No: 16 (25.4); yes: 47 (74.6) |
| Visceral obesity (15, 16): VFA: males >160 cm2; females >80 cm2 | No: 21 (33.3); yes: 42 (66.7) |
| Sarcopenia | |
| SMI (15): | |
| Males: BMI <25 kg/m2 and SMI <43 cm2/m2, or BMI ≥25 and SMI <53 cm2/m2 Females: BMI <25 and SMI <41 cm2/m2, or BMI ≥25 and SMI <41 cm2/m2 | No: 24 (38.1); yes: 39 (61.9) |
| Myosteatosis | |
| SMD (15): BMI <25 and SMD <41 HU, or BMI ≥25 and SMD <33 HU | No: 12 (19.0); yes: 51 (81.0) |
1COVID-19, coronavirus disease; CT, computed tomography; HU, Hounsfield units; SFI, subcutaneous fat index; SMD, skeletal muscle radiodensity; SMI, skeletal muscle index; VFA, visceral fat area.